PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
14-Feb-2023 Wellbeing Subsidiary KGK Science Receives Exemption Under Section 56 of the Controlled Drugs and Substances Act to Begin Psilocybin Clinical Trial Businesswire
14-Feb-2023 Aditxt Forms its Second Subsidiary, Pearsanta, Inc., to Accelerate the Growth of its AditxtScore™ Program and Appoints Healthcare Executive and Current Head of AditxtScore™ Anthony Voorhies to Serve as its President Businesswire
14-Feb-2023 SpyBiotech Appoints Industry Veteran Eddie Gray as Chair of its Board of Directors SpyBiotech
14-Feb-2023 Refeyn launches SamuxMP Auto for automated AAV capsid analysis Refeyn
14-Feb-2023 ACI Group launches Oomph to help solve data visibility challenges for SMEs ACI Group
14-Feb-2023 Up to 2% of adults in Europe, North America, Israel likely have heart failure BMJ
14-Feb-2023 PureTech to Advance LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders and Postpartum Depression PureTech
14-Feb-2023 Savara Announces New Leadership Appointments Businesswire
14-Feb-2023 Tasso High-Volume Liquid Blood Collection Device Earns CE Mark Certification Businesswire
14-Feb-2023 Vaultree Appoints Technology Industry Veteran Rinki Sethi to Its Board of Directors Businesswire
14-Feb-2023 Biosero and Analytik Jena Enter Co-marketing Agreement for Automated Liquid Handling Laboratory Workflow Businesswire
14-Feb-2023 Three Year Follow-Up Results Confirm Efficacy of StemSpine® Procedure for Treating Chronic Lower Back Pain, with No Serious Adverse Effects Businesswire
14-Feb-2023 Ryne Biotechnology Awarded $4 Million from the California Institute for Regenerative Medicine Businesswire
14-Feb-2023 Altasciences Expands Laboratory Capabilities in Columbia Businesswire
14-Feb-2023 Future Technologies Teams with AEGEX Technologies to bring Intrinsically Safe Tablets into Private Cellular Eco-System for Hazardous Environment Client Deployments Businesswire
14-Feb-2023 PureTech to Advance LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders and Postpartum Depression Businesswire
14-Feb-2023 AdaptHealth Corp. Announces Fourth Quarter and Full Year 2022 Earnings Release Date and Conference Call Businesswire
14-Feb-2023 Rectify Pharmaceuticals Expands Clinical Drug Development Expertise with Board and SAB Appointments Businesswire
14-Feb-2023 Novel Approach to Treating Advanced Liver Cancer with Namodenoson Published in Leading Scientific Journal: 12-Month Survival of 44% for Namodenoson vs. 18% for Placebo Businesswire
14-Feb-2023 Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Businesswire